Delving into the Latest Updates on Kaifeng Kangnuo Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Hemic and Lymphatic Diseases

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Hemic and Lymphatic Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

The main purpose of the study is to evaluate the safety and tolerability of single and multiple intravenous administration of different doses of coenzyme I in healthy Chinese adult subjects. The secondary purpose of the study is to evaluate the pharmacokinetic (PK) characteristics of single and multiple intravenous administration of different doses of coenzyme I in healthy Chinese adult subjects.

Start Date13 Jun 2023

Sponsor / Collaborator

Kaifeng Kangnuo Pharmaceutical Co. Ltd.

[+1]

100 Clinical Results associated with Kaifeng Kangnuo Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Kaifeng Kangnuo Pharmaceutical Co. Ltd.

Login to view more data

1

Literatures (Medical) associated with Kaifeng Kangnuo Pharmaceutical Co. Ltd.

Zhongguo Yaoye

Study on extraction technology of Qingremingmu Capsule

Author: Wang, Zhongwei

Objective: To optimize the extraction technol. for Qingremingmu Capsule.Methods: The orthogonal test design was used to test the main factors of extraction process, including the amount of water, decocting time and decocting operation frequency, and the amount of paeoniflorin extraction was used as guide.Results: The optimum condition was adding 8 times amount of water for decocting three times and each time for 1 h.Conclusion: The extraction process is reasonable, which provides the scientific basis for the preparation of Qingremingmu Capsule.

100 Deals associated with Kaifeng Kangnuo Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Kaifeng Kangnuo Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data